Dept. of Molecular Medicine International Publications

     2013 Publications

 1-Ozturk O, Canbay E, Kahraman OT, Fatih Seyhan M, Aydogan F, Celik V, Uras C. HER2 Ile655Val and PTEN IVS4 polymorphisms in patients with breast cancer. Mol Biol Rep. 2013 Feb;40(2):1813-8. Impact factor: 2,929

2-Canbay E, Kahraman OT, Bugra D, Caykara B, Seyhan MF, Bulut T, Yamaner S, Ozturk O. Association between PTEN IVS4 polymorphism and development of colorectal cancer in a Turkish population. Expert Opin Ther Targets. 2013 Jan;17(1):1-6. Impact factor: 3,713

3-Dağlar-Aday A, Toptaş B, Oztürk T, Seyhan F, Saygılı N, Eronat AP, Akadam-Teker B, Yılmaz-Aydoğan H, Aksoy F, Oztürk O. Investigation of BRAF V600E Mutation in Papillary Thyroid Carcinoma and Tumor-Surrounding Nontumoral Tissues.  DNA Cell Biol. 2013 Jan;32(1):13-8. doi: 10.1089/dna.2012.1776. Epub 2012 Nov 16. Impact factor: 2,072

2012 Publications

 4-Yaylim I, Ozkan NE, Turan S, Korkmaz G, Yildiz Y, Cacina C, Topbas B, Arikan S. sTRAIL Serum Levels and TRAIL 1595 Genotypes: Association with Progress and Prognosis of Colorectal Carcinoma. Journal of Cancer Therapy 2012 3:941-947. Impact factor: 0,14

5-Yaylim I, Ozkan NE, Isitmangil T, Isitmangil G, Turna A, Isbir T. CK2 Enzyme Affinity Against c-myc424-434 Substrate in Human Lung Cancer Tissue.Asian Pac J Cancer Prev. 2012;13(10):5233-6. Impact factor: 0,659

 6-Yılmaz-Aydogan H, Kucukhuseyin O, Kurnaz O, Akadam-Teker B, Kurt O, Tekeli A, Ozturk O, Isbir T. Investigation of polymorphic variants of PPARD and APOE genes in Turkish coronary heart disease patients. DNA Cell Biol. 2012 May;31(5):867-75. doi: 10.1089/dna.2011.1464. Epub 2012 Jan 25. Impact factor: 2,072

 7-Ergen HA, Zeybek Ü, Gök Ö, Ermis Karaali Z. Investigation Of ABCA1 C69T Polymorphism In Patients With Diabetes Mellitus Type 2. Biochemia Medica 2012;22(1):114–20. Impact Factor: 1,343

8-Turna A, Pekçolaklar A, Metin M, Yaylim I, Gurses A. The effect of season of operation on thesurvival of patients with resected non-small cell lung cancer.InteractCardiovascThoracSurg. 2012 Feb;14(2):151-5. Impact factor: 2,106

9-Bektas-Kayhan K, Kucukhuseyin O, Karagoz G, Unur M, Ozturk O, Unuvar A, Devecioglu O, Yilmaz-Aydogan H. Is the MDR1 C3435T Polymorphism Responsible for Oral Mucositis in Children with Acute Lymphoblastic Leukemia? Asian Pac J Cancer Prev. 2012;13(10):5251-5. Impact factor: 0,659

10-Ö. Gül, E. Öztürk, M G Uğur, F B Cebesoy, N Kurtul, S Pençe, S Pehlivan, Ö Balat.Preeklamptik Gebelerde Serum Total Sialik Asit Seviyeleri ve Sialik Asit Esteraz Gen Varyasyonu. J Turk Soc Obstet Gynecol. 9(2),99-105. (2012).

11-Colak Y, Senates E, Yesil A, Yilmaz Y, Ozturk O, Doganay L, Coskunpinar E, Kahraman OT, Mesci B, Ulasoglu C, Tuncer I. Assessment of endothelial function in patients with nonalcoholic fatty liver disease. Endocrine. 2012 Jun 3. [Epub ahead of print] PMID:22661277  Impact factor; 1,416

12-Senateş E, Colak Y, Yeşil A, Coşkunpinar E, Sahin O, Kahraman OT, Erkalma Şenateş B, Tuncer I. Circulating resistin is elevated in patients with non-alcoholic fatty liver disease and is associated with steatosis, portal inflammation, insulin resistance and nonalcoholic steatohepatitis scores. Minerva Med. 2012 Oct;103(5):369-76. Impact factor: 0,900

13-Canbay E, Kurnaz O, Canbay B, Bugra D, Cakmakoglu B, Bulut T, Yamaner S, Sokucu N, Buyukuncu Y, Yilmaz-Aydogan H. PPAR-Gamma Pro12Ala Polymorphism and Gastric Cancer Risk in a Turkish Population. Asian Pac J Cancer Prev. 2012;13(11):5875-8. Impact factor: 0,659

14-Gündüz M, Cacına C, Toptaş B, Yaylım-Eraltan I, Tekand Y, Isbir T. Association of vitamin d receptor gene polymorphisms with colon cancer. Genet Test Mol Biomarkers. 2012 Sep;16(9):1058-61. Epub 2012 Aug 1 Impact factor: 0,879

15-Kucukhuseyin O, Yilmaz-Aydogan H, Isbir CS, Isbir T, “Is there any association between GLY82 ser polymorphism of rage gene and Turkish diabetic and non diabetic patients with coronary artery disease?”, Mol Biol Rep. 2012; 39:4423–4428 Impact factor: 2,929

16-Engin Aynaci, Ender Coskunpinar, Ayse Eren, Onur Kum, Yasemin Musteri Oltulu, Nergiz Akkaya, Akif Turna, İlhan Yaylim and Pinar Yildiz. Association between survivin gene promoter -31G/C and -644C/T polymorphisms and non-small cell lung cancer. Genetics and Molecular Research, 2012 (in press) Impact factor: 1,013

17-Ender Coşkunpınar, Sema Anak, Leyla Ağaoğlu, Ayşegül Ünüvar, Ömer Devecioğlu, Gönül Aydoğan, Çetin Timur, Ahmet Faik Öner, Yıldız Yıldırmak, Tiraje Celkan, İnci Yıldız, Nazan Sarper, Uğur Özbek. Analysis of Chromosomal Aberrations and FLT3 gene Mutations in Childhood Acute Myelogenous Leukemia Patients Turk J Hematol 2012; 29 (3) : 225-232 doi: 10.5505/tjh.2012.24392

18-Engin Aynacı, Ender Coşkunpınar, Ayşe Eren, Onur Kum, Yasemin Müşteri Oltulu, Nergiz Akkaya, Akif Turna, İlhan Yaylım, Pınar Yıldız. Investigation of the association of survivin gene -625G/C polymorphism in non-small cell lung cancer. Journal of Cell and Molecular Biology 2012, 10(1):27-32, Haliç University.

19-Eraltan H, Cacina C, Kahraman OT, Kurt O, Aydogan HY, Uyar M, Can A, Cakmakoğlu B. MCP-1 and CCR2 gene variants and  the risk for osteoporosis and osteopenia. Genet Test Mol Biomarkers. 2012 Apr;16(4):229-33. Epub 2011 Nov 14. PMID:22081934 Impact factor: 0,879

20-Akbas F, Coskunpinar E, Aynacı E, Oltulu YM, Yildiz.P. Analysis of serum miRNAs as potential biomarker in COPD. Exp Lung Res. 2012 2012 Aug;38(6):286-94. Impact factor: 1,180

21-Colak Y, Senates E, Ozturk O, Doganay HL, Coskunpinar E, Oltulu YM, Eren A, Sahin O, Ozkanli S, Enc FY, Ulasoglu C, Tuncer I. Association of serum lipoprotein-associated phospholipase A2 level with nonalcoholic fatty liver disease. Metab Syndr Relat Disord. 2012 Apr;10(2):103-9. Impact factor: 1,932

22-Senateş E, Colak Y, Erdem ED, Yeşil A, Coşkunpınar E, Sahin O, Altunöz ME, Tuncer I, Kurdaş Övünç AO. Serum anti-Müllerian hormone levels are lower in reproductive-age women with Crohn’s disease compared to healthy control women. J Crohns Colitis. 2012 Apr 1. [Epub ahead of print] PubMed PMID: 22472089 Impact factor: 2,628

23-Mogulkoc U., Coskunpinar E., Caglar E., Ortaköylü G., Ozkan G., Musteri Oltulu Y., Yaylim-Eraltan I. Is MMP-7 Gene Polymorphism A Possible Risk Factor For Copd In Turkish Patients. Genet Test Mol Biomarkers. 2012 Jun;16(6):519-23. Epub 2012 Mar 14. Impact factor: 0,879

24-Sahin O, Arikan S, Musteri Oltulu Y, Coskunpinar E, Eren A, Cacina C, Guler E, Yaylim I.Investigation of a Possible Relationship Between EPHX1 Gene Polymorphisms and Colorectal Cancer in Turkish Society. Genet Test Mol Biomarkers. 2012 Feb 21. [Epub ahead of print]. Impact factor: 0,879

25-Gurdol F, Cakmakoglu B, Dasdemir S, Isbilen E, Bekpinar S, Isbir T. -765 G→C and -1195 A→G Promoter Variants of the Cyclooxygenase-2 Gene Decrease the Risk for Preeclampsia. Genet Test Mol Biomarkers. 2012 Jan 6. [Epub ahead of print] PubMed PMID: 22224631. Impact factor: 0,879

26-Bektas-Kayhan K, Unur M, Boy-Metin Z, Cakmakoglu B. MCP-1 and CCR2 gene variants in oral squamous cell carcinoma. Oral Dis. 2012 Jan;18(1):55-9. doi: 10.1111/j.1601-0825.2011.01843.x. Epub 2011 Aug 24. PMID:21883707 Impact factor: 2,145

27-Inal Gultekin G, Raj K, Lehman S, Hillström A, Giger U. Missense mutation in PFKM associated with muscle-type phosphofructokinase deficiency in the Wachtelhund dog. Mol Cell Probes. 2012 Mar 16. [Epub ahead of print]  PMID:22446493  Impact Factor: 2,078.

28-Inal Gultekin G, Raj K, Foureman P, Lehman S, Manhart K, Abdulmalik O, Giger U. Erythrocytic Pyruvate Kinase Mutations Causing Hemolytic Anemia, Osteosclerosis, and Secondary Hemochromatosis in Dogs. J Vet Intern Med. 2012 Jul 13. doi: 10.1111/j.1939-1676.2012.00958.x. [Epub ahead of print]  PMID:22805166  Impact Factor: 1.992.

 29-Kurt O, Yilmaz-Aydogan H, Uyar M, Isbir T, Seyhan MF, Can A. Evaluation of ERa and VDR gene polymorphisms in relation to bone mineral density in Turkish postmenopausal women.  Mol Biol Rep. 2012 Jun;39(6):6723-30. Epub 2012 Feb 7. Impact factor: 2,929

30-Aydoğan HY, Küçükhüseyin O, Tekeli A, Isbir T. Associations of Receptor For Advanced Glycation End Products (RAGE) -374 T/ A and Gly82 Ser and Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) Pro12Ala Polymorphisms In Turkish Coronary Artery Disease Patients. Genet Test Mol Biomarkers. 2012 Feb;16(2):134-7. Epub 2011 Aug 23. PMID:21861709 Impact factor: 0,879

31-Yildiz I, Unuvar E, Zeybek U, Toptas B, Toprak SK, Cacina C, Kilic A, Aydin S. The role of vitamin D in children with recurrent Tonsillopharyngitis. Ital J Pediatr. 2012 Jun 8;38(1):25. [Epub ahead of print]. PMID:22682426  Impact factor: 0,791

32-Baş F, Darendeliler F, Aycan Z, Cetinkaya E, Berberoğlu M, Sıklar Z, Ocal G, Timirci O, Cetinkaya S, Darcan S, Gökşen Şimşek D, Bideci A, Cinaz P, Böber E, Demir K, Bereket A, Turan S, Atabek ME, Tütüncüler F, Isbir T, Bozkurt N, Kabataş Eryılmaz S, Uzunhan O, Küçükemre Aydın B, Bundak R. The exon 3-deleted/full-length growth hormone receptor polymorphism and response to growth hormone therapy in growth hormone deficiency and turner syndrome: a multicenter study. Horm Res Paediatr. 2012;77(2):85-93. Epub 2012 Mar 23. PMID:22456308 Impact factor; 2,48

 33-Colak Y, Senates E, Yesil A, Yilmaz Y, Ozturk O, Doganay L, Coskunpinar E, Kahraman OT, Mesci B, Ulasoglu C, Tuncer I. Assessment of endothelial function in patients with nonalcoholic fatty liver disease. Endocrine. 2012 Jun 3. [Epub ahead of print] PMID:22661277  Impact factor; 1,416

34-Canbay E, Ergen A, Bugra D, Yamaner S, Eraltan IY, Buyukuncu Y, Bulut T. Kisspeptin-54 Levels are increased in Patients with Colorectal Cancer. World J Surg. 2012 May 3. [Epub ahead of print] PMID:22552499 Impact factor: 2,693

35-Eren Z, Kantarci G, Biyikli N, Arikan H, Tuglular S, Ergen A, Isbir T, Akoglu E.  Paraoxonase 1 polymorphisms in patients with primary glomerulonephritis: a single-center study in Turkey. Iran J Kidney Dis. 2012 May;6(3):181-5. PMID:22555481 Impact factor: 0,870

36-Tükel R, Arslan BA, Ertekin BA, Ertekin E, Oflaz S, Ergen A, Kuruca SE, Isbir T. Decreased IFN-γ and IL-12 levels in panic disorder. J Psychosom Res. 2012 Jul;73(1):63-7. Epub 2012 May 20. PMID: 22691562 Impact factor: 3,269

37-Cincin ZB, Iyibozkurt AC, Kuran SB, Cakmakoglu B. DNA repair gene variants in endometrial carcinoma. Med Oncol. 2012 Jan 22. [Epub ahead of print]  PMID:22271435 Impact factor: 2,140

38-Gurdol F, Yurdum LM, Ozturk U, Isbilen E, Cakmakoglu B. Association of the CC chemokine receptor 5 (CCR5) polymorphisms with preeclampsia in Turkish women. Arch Gynecol Obstet. 2012 Feb 5. [Epub ahead of print] PMID: 22314435 Impact factor: 1,277

39-Kucukgergin C, Isman FK, Cakmakoglu B, Sanli O, Seckin S. Association of Polymorphisms in MCP-1, CCR2, and CCR5 Genes with the Risk and Clinicopathological Characteristics of Prostate Cancer. DNA Cell Biol. 2012 May 21. [Epub ahead of print] PubMed PMID: 22612293. Impact factor: 2,072

40-Gencer M, Dasdemir S, Cakmakoglu B, CetinkayaY, Varlibas F, Tireli H, Kucukali CI, Ozkok E, Aydin M. DNA repair genes in parkinson’s disease. Genet Test Mol Biomarkers. 2012 Jun;16(6):504-7.  Epub 2012 Jan 6. PMID: 22224629 Impact factor: 0,879

41-Kurnaz O, Akadam-Teker A.B, Yilmaz- Aydogan H, Tekeli A, İsbir  T. LOX-1 3’UTR188CT Polymorphism and coronary artery disease in Turkish patients .Mol Biol Rep. 2012 Apr;39(4):4351-8.  Epub 2011 Sep 7. PMID:21901421 Impact factor: 2,929

42-Arıkan S, Cacina C, Guler E, Çulcu S, Tuna G, Yaylım-Eraltan I. The effects of NOS3 Glu298Asp variant on colorectal cancer risk and progression in Turkish population. . Mol Biol Rep. 2012 Mar;39(3):3245-9. doi: 10.1007/s11033-011-1092-8. Impact Factor: 1,875

2011 Publications

 43-Acilmis YG, Dikensoy E, Kutlar AI, Balat O, Cebesoy FB, Ozturk E, Cicek H, Pence S. Homocysteine, folic acid and vitamin b12 levels in maternal and umbilical cord plasma and homocysteine levels in placenta in pregnant women with preeclampsia. J Obstet Gynaecol Res. 2011 Jan;37(1):45-50. doi: 10.1111/j.1447-0756.2010.01317.x. Epub 2010 Oct 11. PMID:21040211 Impact Factor: 0,869

44-Ozturk E, Balat O, Ugur M, Yazicioglu C,  Pence s, Erel  O, Kul S.   Effect of ramadan fastıng on maternal oxidatıve stress during the second trimester: a preliminary study. The Journal of Obstet Gynaecol Res. 2011 Jul;37(7):729-33. Impact Factor: 0,869

45-Ozturk E, Balat O, Acılmıs Y, Ozcan C, Pence S, Erel  O. Measurement of the       placental total antıoxıdant status in preeclamptic women using a novel automated   method. J Obstet Gynaecol Res. 2011 Jul;37(7):729-33. doi: 10.1111/j.1447-0756.2010.01419.x. Epub 2011 Mar 9. PMID:21736666 Impact Factor: 0,869

46-Atik B, Erkutlu I,Tercan M, Buyukhatipoglu M, Bekerecioglu M, Pence S. The effects of exogenous melatonin on peripheral nerve regeneration and collagen formation in rats. J Surg Res. 2011 Apr;166(2):330-6. Epub 2009 Jul 10. PMID: 20006352 Impact Factor:2,239

47-Küçükhüseyin Ö, Kurnaz Ö, Akadam-Teker AB, Narter F, Yılmaz-Aydoğan H, İsbir T. Effects of the MTHFR C677T Polymorphism on Prostate Specific Antigen and Prostate Cancer. Asian Pac J Cancer Prev. 2011;12(9):2275-8. PMID:22296369  Impact Factor:1,240

 48-Yilmaz-Aydogan H, Kurnaz O, Kurt O, Akadam-Teker B, Kucukhuseyin O, Tekeli A, Isbir T. Effects of the PPARG P12A and C161T Gene Variants on Serum Lipids in Coronary Heart Disease Patients with and without Type 2 Diabetes. Mol Cell Biochem. 2011 Dec;358(1-2):355-63. Epub 2011 Jul 21. PMID: 21833536 Impact Factor: 2,168.

49-Kucukhuseyin O, Yilmaz-Aydogan H, Isbir CS, Isbir T. Is there any association   between GLY82 ser polymorphism of rage gene and Turkish diabetic and non diabetic patients with coronary artery disease? Mol Biol Rep. 2012 Apr;39(4):4423-8.  Epub 2011 Sep 25. PMID:21947881 Impact factor : 1,875 (SCI). Impact Factor: 1,875.

50-Kurt  O, Aydogan Yilmaz H, Uyar  M, Seyhan  MF, Isbir  T,  Can  A. Assocıatıon Between Collagen Type I [A](1) (Col1a1) Gene Polymorphısm Wıth Bone Mıneral Densıty In Turkısh Postmenopausal Women. Osteoporosıs Int. 2011;22(1);180-181. Impact Factor: 4,859.

51-Cacina C, Bulgurcuoglu-Kuran S, Iyibozkurt AC, Yaylim-Eraltan I, Cakmakoglu B. Genetic variants of SDF-1 and CXCR4 genes in endometrial carcinoma. Mol Biol Rep. 2012;39(2):1225-9. Epub 2011 May 24. PMID:21607621 Impact Factor: 1,875.

52-Turna A, Pekçolaklar A, Metin M, Yaylim I, Gurses A. The effect of season of operation on the survival of patients with resected non-small cell lung cancer. Interact Cardiovasc Thorac Surg. 2012 Feb;14(2):151-5. Epub 2011 Nov 30. PMID: 22159250 Impact Factor: 0,753.

53-Isbir O, Gormuş U, Ergen HA, Cakmakoğlu B, Kahraman OT, Baykan N. XPD and hOGG1 gene polymorphisms in reperfusion oxidative stress. Genet Mol Res. 2011 Dec 19;10(4):3157-62. PMID:22194171 Impact Factor: 1,013.

54-Agachan Cakmakoglu B, Attar R, Kahraman OT, Dalan AB, Iyibozkurt AC, Karateke A, Attar E. Cyclooxygenase-2 gene and epithelial ovarian carcinoma risk. Mol Biol Rep. 2011 Jun;38(5):3481-6. Epub 2010 Nov 24. PMID: 21107726 Impact Factor: 1,875.

55-Coskunpinar E, Eraltan IY, Turna A, Agachan B. Cyclooxygenase-2 gene and lung carcinoma risk. Med Oncol. 2011 Dec;28(4):1436-40. Epub 2010 Jul 20. PMID:20645029 Impact Factor: 2,220.

56-Colak Y, Senates E, Ozturk O, Yilmaz Y, Coskunpinar E, Kahraman OT, Sahin O, Zemheri E, Enc FY, Ulasoglu C, Kiziltas S, Kurdas OO, Tuncer I. Plasma Fibrinogen-Like Protein 2 Levels in Patients with Non-Alcoholic Fatty Liver Disease. Hepatogastroenterology. 2011 Nov-Dec;58(112):2087-90. doi: 10.5754/hge11248. PMID:22024080 Impact Factor: 0,677.

57-Aydın S, Aslan I, Yıldız I, Ağaçhan B, Toptaş B, Toprak S, Değer K, Oktay MF, Unüvar E. Vitamin D levels in children with recurrent tonsillitis. Int J Pediatr Otorhinolaryngol. 2011 Mar;75(3):364-7. Epub 2011 Jan 7. PMID:21215466 Impact Factor: 1,607.

58-Canbay E, Cakmakoglu B, Zeybek U, Sozen S, Cacina C, Gulluoglu M, Balik E,Bulut T, Yamaner S, Bugra D. Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in a Turkish population. Curr Med Res Opin. 2011 Jul;27(7):1295-302. Epub 2011 May 12. PMID:21561390 Impact Factor: 2,609.

59-Zeybek U, Toptas B, Karaali ZE, Kendir M, Cakmakoglu B. Effect of TNF-α and IL-1β genetic variants on the development of myocardial infarction in Turkish population. Mol Biol Rep. 2011 Nov;38(8):5453-7. Epub 2011 Mar 6. PMID:21380730 Impact Factor: 1,875.

60-Baş F, Keleşoğlu F, Timirci Ö, Kabataş Eryılmaz S, Bozkurt N, Küçükemre Aydın B, Bundak R, Isbir T, Darendeliler F. The distribution of exon 3-deleted/full-length growth hormone receptor polymorphism in the Turkish population. J Clin Res Pediatr Endocrinol. 2011;3(3):126-31. doi: 10.4274/jcrpe.v3i3.25. PMID: 21911325

61-Aydoğan HY, Küçükhüseyin O, Tekeli A, Isbir T. Associations of Receptor for Advanced Glycation End Products -374 T/A and Gly82 Ser and Peroxisome Proliferator-Activated Receptor Gamma Pro12Ala Polymorphisms in Turkish Coronary  Artery Disease Patients. Genet Test Mol Biomarkers. 2012 Feb;16(2):134-7. Epub 2011 Aug 23. PMID: 21861709 Impact factor :0,879 (SCI-ex.) Impact factors:0,879

62-Aksoy-Sagirli P, Cakmakoglu B, Isbir T, Kaytan-Saglam E, Kizir A, Topuz E,Berkkan H. Paraoxonase-1 192/55 polymorphisms and the risk of lung cancer in a Turkish population. Anticancer Res. 2011 Jun;31(6):2225-9. PMID: 21737645 Impact factor:1,656

63-Ozturk T, Kahraman OT, Toptaş B, Kisakesen HI, Çakalir C, Verim L, Ozturk O, Isbir T. The effect of CYP1A1 and GSTM1 gene polymorphisms in bladder cancer development in a Turkish population. In Vivo. 2011 Jul-Aug;25(4):663-8. PMID:21709011 Impact factor:1,159

64-Toptas B, Gormuş U, Ergen A, Gurkan H, Kelesoglu F, Darendeliler F, Bas F, Dalan AB, Izbirak G, Isbir T. Comparison of lipid profiles with APOA1 MspI polymorphism in obese children with hyperlipidemia. In Vivo. 2011 May-Jun;25(3):425-30. PMID:21576418 Impact factor:1,159

65-Gormuş U, Kahraman OT, Isbir S, Tekeli A, Isbir T. MMP2 gene polymorphisms and MMP2 mRNA levels in patients with superficial varices of lower extremities. In Vivo. 2011 May-Jun;25(3):387-91. PMID:21576412 Impact factor:1,159

66-Ol KK, Agachan B, Gormus U, Toptas B, Isbir T. Cox-2 gene polymorphism and IL-6 levels in coronary artery disease. Genet Mol Res. 2011 May 10;10(2):810-6. PMID:21574137 Impact factor:1,013

67-Narter F, Can G, Ergen A, Isbir T, Ince Z, Çoban A. Neonatal hyperbilirubinemia and G71R mutation of the UGT1A1 gene in Turkish patients. J Matern Fetal Neonatal Med. 2011 Feb;24(2):313-6. Epub 2010 Jun 8. PMID:20528217 Impact factor:2,071

68-Ergul Ekiz, E., Arslan, M., Ozcan, M., Inal Gültekin, G., Yildiz Gulay, O. Kirmizibayrak, T., Giger. U. Frequency of dog erythrocyte antigen 1.1 in 4 breeds native to different areas in Turkey.Vet Clin Pathol. 2011 Dec;40(4):518-23. doi: 10.1111/j.1939-165X.2011.00370.x. PMID:22136478 Impact factor:1,239

69-Emre S, Sirin A, Ergen A, Bilge I, Sucu A, Yilmaz A, Isbir T. Methylenetetrahydrofolate Reductase C677T Polymorphism In Patients With Henoch-Schönlein Purpura. Pediatr Int. 2011 Jun;53(3):358-62. doi: 10.1111/j.1442-200X.2010.03247.x. PMID:20831652 Impact factor:0,755

70-Matur, E., Ergül, E., Akyazı, I., Eraslan, E., Inal Gultekin, G., Bilgiç, S., Demircan, H.: Effects of Saccharomyces cerevisiae extract on haematological parameters, immune function and the antioxidant defence system in breeder hens fed aflatoxin contaminated diets.Br Poult Sci. 2011 Oct;52(5):541-50. PMID:22029780 Impact factor:1,033

71-Yarat A, Ozturk LK, Ulucan K, Akyuz S, Atala H, Isbir T. Carbonic anhydrase VI exon 2 genetic polymorphism in Turkish subjects with low caries experience (preliminary study). In Vivo. 2011 Nov Dec;25(6):941-4. PubMed PMID: 22021688. Impact factor:1,159

72-Ergen A, İsbir S, Timirci O, Tekeli A, Isbir T. Effects of myeloperoxidase -463 G/A gene polymorphism and plasma levels on coronary artery disease. Mol Biol Rep. 2011 Feb;38(2):887-91. Epub 2010 Jun 22. PMID:20568015 Impact Factor: 1,875.

73-Tetik S, Ak K, Sahin Y, Gulsoy O, Isbir S, Arsan S, Yardimci T. Postoperative statin therapy attenuates the intensity of systemic inflammation and increases fibrinolysis after coronary artery bypass grafting. Clin Appl Thromb Hemost. 2011 Oct;17(5):526-31. Epub 2010 Aug 30. PubMed PMID: 20805103. Impact factor:1,476

74-Acilmis YG, Dikensoy E, Kutlar AI, Balat O, Cebesoy FB, Ozturk E, Cicek H, Pence S.Homocysteine, folic acid and vitamin B12 levels in maternal and umbilical cord plasma and homocysteine levels in placenta in pregnant women with pre‐eclampsia.J Obstet Gynaecol Res. 2011 Jan;37(1):45-50. doi: 10.1111/j.1447-0756.2010.01317.x. Epub 2010 Oct 11. Impact factor:1,869

 75-Ergen A, Kılıcoglu O, Ozger H, Agachan B, Isbir T. Paraoxonase 1 192 and 55 polymorphisms in osteosarcoma. Mol Biol Rep. 2011 Aug;38(6):4181-4. Epub 2010 Nov 23. PMID: 21104436 Impact Factor: 1,875.

76-Ozturk E, Balat O, Acılmıs YG, Ozcan C, Pence S, Erel Ö.Measurement of the placental total antioxidant status in preeclamptic women using a novel automated method. J Obstet Gynaecol Res. 2011 Apr;37(4):337-42. doi: 10.1111/j.1447-0756.2010.01346.x. Epub 2011 Feb 11. Impact factor:1,869

77-Atik B, Erkutlu I, Tercan M, Buyukhatipoglu H, Bekerecioglu M, Pence S.The effects of exogenous melatonin on peripheral nerve regeneration and collagen formation in rats.J Surg Res. 2011 Apr;166(2):330-6. Epub 2009 Jul 10. Impact Factor:2,239

 2010 Publications

 78-Bahat G, Saka B, Erten N, Ozbek U, Coskunpinar E, Yildiz S, Sahinkaya T, Karan MA. BsmI polymorphism in the vitamin D receptor gene is associated with leg extensor muscle strength in elderly men. Aging Clin Exp Res. 2010 Jun;22(3):198-205. Impact factor:1,693

79-Arzu Ergen, Özlem Timirci Kahraman, Ümit Zeybek, Özlem Gök, Özlem Karatoprak, Turgay İsbir. Diyabetik nefropatide myeloperoksidaz gen polimorfizminin incelenmesi. Diabet Bilimi, Kasım 2010, Cilt 8/ Sayı 6; 227-231.

80-Ofluoglu  D, Zebrek  U, Kucukhuseyin  O, Isbir  T, Tanyeri H. Research of Methylenetetrahydrofolate Reductase Gene Polymorphism in Recurrent Aphthous Stomatitis Patients. Oral Dıs. 2010;16(6);545-546. Impact factor:2,145

81-Erkisi Z, Yaylim-Eraltan I, Turna A, Gormus U, Camlica H, Isbir T. Polymorphisms in the microsomal epoxide hydrolase gene: role in lung cancer susceptibility and prognosis. Tumori. 2010 Sep-Oct;96(5):756-63. PMID:21302624 Impact factor:1,014

82-Bucak  F Tahmiscioglu, Durmaz  O, Gulluoglu  M, Ergen A, Ozden  T, Ongen  B, Isbir  T, Sokucu  S. Genetıc Polymorphısms Determınıng Host Response Of Chıldren Infected Wıth Helıcobacter Pylorı. Journal Of Pedıatrıc Gastroenterology And Nutrıtıon. 2010;50(2);E6-E7. Impact factor:2,180

83-Canbay  E, Agachan  B, Gulluoglu M, Isbir  T, Balik  E, Yamaner  S, Bulut  T, Zeybek  U, Sozen  S, Cacina C, Yilmaz  A, Bugra  D. Assocıatıon Of Colorectal Cancer Development And Prognosıs Wıth Dna Repaır Genes. Dıseases Of The Colon & Rectum. 2010;53(4);657-657. Impact factor:2,819

84-Attar R, Cacina C, Sozen S, Attar E, Agachan B. DNA repair genes in endometriosis Genet Mol Res. 2010 Apr 6;9(2):629-36. PMID: 20391347 Impact factor:1,184

85-Canbay E, Agachan B, Ozturk T, Giris M, Asoglu O, Balik E, Bugra D. Dual inhibition of wound healing and oxidative process by montelukast in experimental colon anastomoses. Surg Innov. 2010 Sep;17(3):248-55. Epub 2010 Jul 15. Impact factor:2,255

86-Bektas-Kayhan K, Unür M, Yaylim-Eraltan I, Ergen HA, Toptas B, Hafiz G, Karadeniz A, Isbir T. Association of vitamin D receptor Taq I polymorphism and susceptibility to oral squamous cell carcinoma. In Vivo. 2010 Sep-Oct;24(5):755-9. PMID: 20952745 Impact factor:1,159

87-Agachan B, Attar R, Isbilen E, Aydogan HY, Sozen S, Gurdol F, Isbir T. Association of monocyte chemotactic protein-1 and CC chemokine receptor 2 gene variants with preeclampsia. J Interferon Cytokine Res. 2010 Sep;30(9):673-6. PMID: 20726788 Impact factor:2,576

88-Canbay E, Eraltan IY, Cercel A, Isbir T, Gazioglu E, Aydogan F, Cacina C, Cengiz A, Ferahman M, Zengin E, Unal H. CCND1 and CDKN1B polymorphisms and risk of breast cancer. Anticancer Res. 2010 Jul;30(7):3093-8. PMID: 20683061 Impact factor:1,725

89-Ozbek YK, Oztürk T, Tüzüner BM, Calay Z, Ilvan S, Seyhan FM, Kisakesen HI, Oztürk O, Isbir T. Combined effect of CYP1B1 codon 432 polymorphism and N-acetyltransferase 2 slow acetylator phenotypes in relation to breast cancer in  the Turkish population. Anticancer Res. 2010 Jul;30(7):2885-9. PMID: 20683028 Impact factor:1,656

90-Yaylim-Eraltan I, Arikan S, Yildiz Y, Cacina C, Ergen HA, Tuna G, Gormus U, Zeybek U, Isbir T. The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population. Anticancer Res. 2010 Jul;30(7):2875-80. PMID:20683026 Impact factor:1,656

91-Attar R, Agachan B, Kuran SB, Toptas B, Eraltan IY, Attar E, Isbir T. Genetic variants of vascular endothelial growth factor and risk for the development of endometriosis. In Vivo. 2010 May-Jun;24(3):297-301. PMID: 20555002 Impact factor:1,159

92-Canbay E, Agachan B, Gulluoglu M, Isbir T, Balik E, Yamaner S, Bulut T, Cacina C, Eraltan IY, Yilmaz A, Bugra D. Possible associations of APE1 polymorphism with susceptibility and HOGG1 polymorphism with prognosis in gastric cancer. Anticancer Res. 2010 Apr;30(4):1359-64. PMID: 20530453 Impact factor:1,656

93-Narter KF, Agachan B, Sozen S, Cincin ZB, Isbir T. CCR2-64I is a risk factor for development of bladder cancer. Genet Mol Res. 2010 Apr 13;9(2):685-92. PMID: 20449800 Impact factor:1,013

94-Attar R, Agachan B, Kuran SB, Cacina C, Sozen S, Yurdum LM, Attar E, Isbir T.Association of CCL2 and CCR2 gene variants with endometrial cancer in Turkish women. In Vivo. 2010 Mar-Apr;24(2):243-8. PMID: 20364004 Impact factor:1,159

95-Cacina C, Yaylim-Eraltan I, Arikan S, Saglam EK, Zeybek U, Isbir T. Association between CDKN1A Ser31Arg and C20T gene polymorphisms and colorectal cancer risk and prognosis. In Vivo. 2010 Mar-Apr;24(2):179-83. PMID: 20363991 Impact factor:1,159

96-Yildiz  Yemliha, Yaylim-Eraltan  Ilhan, Arikan  Soykan, Ergen  H. Arzu, Kucucuk  Seden, Isbir Turgay. Is there any correlation between TNF-related adoptosis-inducing ligand (TRAIL) genetic variants and breast cancer? Archıves Of Medıcal Scıence. 2010;6(6);932-936. Impact factor:1,199

97-Karaali ZE, Sozen S, Yurdum M, Cacina C, Toptas B, Gok O, Agachan B. Effect of genetic variants of chemokine receptors on the development of myocardial infarction in Turkish population. Mol Biol Rep. 2010 Oct;37(7):3615-9. Epub 2010 Feb 25. PMID: 20182805 Impact Factor: 1,875.

98-Tuzuner BM, Ozturk T, Kisakesen HI, Ilvan S, Zerrin C, Oztürk O, Isbir T. CYP17 (T-34C) and CYP19 (Trp39Arg) polymorphisms and their cooperative effects on breast cancer susceptibility. In Vivo. 2010 Jan-Feb;24(1):71-4.  PMID: 20133979 Impact factor:1,159

99-Timirci O, Darendeliler F, Bas F, Arzu EH, Umit Z, Isbir T. Comparison of lipid profiles in relation to APOB EcoRI polymorphism in obese children with hyperlipidemia. In Vivo. 2010 Jan-Feb;24(1):65-9. PMID:20133978 Impact factor:1,159

 2009 Publications

 100-Taşkin EI, Akgün-Dar K, Kapucu A, Osanç E, Doğruman H, Eraltan H, Ulukaya E. Apoptosis-inducing effects of Morinda citrifolia L. and doxorubicin on the Ehrlich ascites tumor inBalb-c mice.Cell Biochem Funct. 2009 Dec;27(8):542-6.

101-Kurnaz O, Aydogan HY, Isbir CS, Tekeli A, Isbir T. Is LOX-1 K167N polymorphism protective for coronary artery disease? In Vivo. 2009 Nov-Dec;23(6):969-73 PMID:20023241 Impact factor:1,159

102-Kucukhuseyin O, Aydogan HY, Isbir CS, Isbir T. Associations of -374T/A polymorphism of receptor for advanced glycation end products (RAGE) gene in Turkish diabetic and non-diabetic patients with coronary artery disease. In Vivo. 2009 Nov-Dec;23(6):949-54. PMID:20023238 Impact factor:1,159

103-Darendeliler  F,Bas Firdevs, Bozkurt  Nilufer, Uzunhan  Ozan, Aycan   Zehra, Cetinkaya  Ergun, Berberoglu  Merih, Siklar  Zeynep, Ocal  Gonul, Darcan  Sukran,Goksen  Damla, Bideci  Aysun, Cinaz Peyami, Guran  Tulay, Bober  Ece, Tutunculer  Filiz, Bundak  Ruveyde, Isbir  Turgay. The exon 3 deleted/full length growth hormone receptor polymorphism and response to GH therapy in GH deficiency and Turner syndrome: a multicenter study . Hormone Research. 2009;72(3);109-109.

104-Yilmaz A, Emre S, Agachan B, Bilge I, Yilmaz H, Ergen A, Isbir T, Sirin A. Effect of paraoxonase 1 gene polymorphisms on clinical course of Henoch-Schönlein purpura. J Nephrol. 2009 Nov-Dec;22(6):726-32. PMID:19967651

105-Oztürk O, Kağnici OF, Oztürk T, Durak H, Tüzüner BM, Kisakesen HI, Cakalir C, Isbir T. 192R allele of paraoxanase 1 (PON1) gene as a new marker for susceptibility to bladder cancer. Anticancer Res. 2009 Oct;29(10):4041-6. PMID:19846948

106-Yaylim-Eraltan I, Ergen A, Görmüs U, Arikan S, Küçücük S, Sahin O, Yigit N, Yildiz Y, Isbir T. Breast cancer and cyclin D1 gene polymorphism in Turkish women. In Vivo. 2009 Sep-Oct;23(5):767-72. PMID:19779113 Impact factor:1,159

107-Attar R, Agachan B, Kucukhuseyin O, Toptas B, Attar E, Isbir T. Association of interleukin 1beta gene (+3953) polymorphism and severity of endometriosis in Turkish women. Mol Biol Rep. 2010 Jan;37(1):369-74. PMID:19757173 İmpact Factor: 1,875.

108-Bektas-Kayhan K, Unür M, Yaylim-Eraltan I, Ergen A, Hafiz G, Karadeniz A, Isbir T. Role of L-MYC polymorphism in oral squamous cell carcinoma in Turkey. Anticancer Res. 2009 Jul;29(7):2519-24. PMID:19596922

109-Agaçhan B, Kuçukhuseyin O, Aksoy P, Turna A, Yaylim I, Gormus U, Ergen A, Zeybek U, Dalan B, Isbir T. Apurinic/apyrimidinic endonuclease (APE1) gene polymorphisms and lung cancer risk in relation to tobacco smoking. Anticancer Res. 2009 Jun;29(6):2417-20. PMID:19528510

110-Isbilen E, Yilmaz H, Arzu Ergen H, Unlucerci Y, Isbir T, Gurdol F. Association of paraoxonase 55 and 192 gene polymorphisms on serum homocysteine concentrations in preeclampsia. Folia Biol (Praha). 2009;55(2):35-40. PMID:19454176

111-Arpaci A, Görmüs U, Dalan B, Berkman S, Isbir T. Investigation of PON1 192 and PON1 55 polymorphisms in ovarian cancer patients in Turkish population. In Vivo. 2009 May-Jun;23(3):421-4. PMID:19454508 Impact factor:1,159

112-Karakas  Z, Atasever  B, Kuruca  S. Erdem, Erman  B, Ergen  A, Isbir  T, Agaoglu  L. Natural Kıller Actıvıty And Effect Of Il-2 In Patıents Wıth Beta-Thalassemıa Major. Haematologıca-The Hematology Journal. 2009;94;502-502.

113-Kalay E, Ergen A, Narter F, Agaçhan B, Gormus U, Yigit N, Isbir T. ARE-I polymorphism on PSA gene in prostate cancer patients of a Turkish population. Anticancer Res. 2009 Apr; 9(4):1395-8. PMID:19414393

114-Atasever  B, Kuruca  S. Erdem, Karakas  Z, Erman B, Ergen  A, Isbir  T, Gunal  G. Phenotypıc And Functıonal Studıes Of Natural Kıller (Nk) Cell Subsets In Beta-Thalassemıa Major Patıents. Haematologıca-The Hematology Journal. 2009;94;500-501.

115-Narter KF, Ergen A, Agaçhan B, Gormus U, Timirci O, Isbir T. Bladder cancer and polymorphisms of DNA repair genes (XRCC1, XRCC3, XPD, XPG, APE1, hOGG1). Anticancer Res. 2009 Apr;29(4):1389-93. PMID:19414392

116-Aydogan HY, Isbir S, Kurnaz O, Gormus U, Isbir T. Associations of lipoprotein lipase S447X and apolipoprotein E genotypes with low-density lipoprotein subfractions in Turkish patients with coronary artery disease. In Vivo. 2009 Jan-Feb;23(1):155-61. PMID:19368142 Impact factor:1,159

117-Zejnilovic J, Akev N, Yilmaz H, Isbir T. Association between manganese superoxide dismutase polymorphism and risk of lung cancer. Cancer Genet Cytogenet. 2009 Feb;189(1):1-4. PMID:19167605

118-Cizmecioglu, F.M., N. Etiler, A. Ergen, U. Gormus, A. Keser, N. Hekim, O. Hamzaoglu, S. Hatun.Association of Adiponectin, Resistin and High Sensitive CRP Level with the Metabolic Syndrome in Childhood and Adolescence. Exp Clin Endocrinol Diabetes. 2009; 117(10):622-7.

119-Dikensoy E, Balat O, Pence S, Akcali C, Cicek H.The risk of hepatotoxicity during long-term and low-dose flutamide treatment in hirsutism.Arch Gynecol Obstet. 2009 Mar;279(3):321-7. Epub 2008 Jul 8.

120-Dikensoy E, Balat O, Pence S, Balat A, Cekmen M, Yurekli M.The changes of plasma malondialdehyde, nitric oxide, and adrenomedullin levels in patients with preeclampsia.Hypertens Pregnancy. 2009 Aug;28(4):383-9.

121-Pençe S, Erkutlu I, Kurtul N, Alptekin M, Tan U.Effects of progesterone on total brain tissue adenosine deaminase activity in experimental epilepsy.Int J Neurosci. 2009;119(2):204-13.

2008 Publications

122-Pence S, Bosnak M, Kurtul N, Ugur MG, Erkutlu I, Bagci C, Tan U.The effect of progesterone on total brain tissue sialic acid levels in experimental epilepsy.Int J Neurosci. 2008 Jan;118(1):105-18.

123-Isbir S, Ergen A, Yilmaz H, Tekeli A, Arsan S. Effect of Ala16Val genetic polymorphism of MnSOD on antioxidant capacity and inflammatory response in open heart surgery. In Vivo. 2008 Jan-Feb;22(1):147-51.

124-Tan U, Pençe S, Yilmaz M, Ozkur A, Karaca S, Tan M, Karataş M.“Unertan Syndrome” in two Turkish Families in Relation to Devolution and Emergence of Homo Erectus: Neurological Examination, MRI, and pet Scans.Int J Neurosci. 2008 Mar;118(3):313-36.

125-Tan U, Karaca S, Tan M, Yilmaz B, Bagci NK, Ozkur A, Pence S.Unertan syndrome: A case series demonstrating human devolution.Int J Neurosci. 2008 Jan;118(1):1-25.

126-Dikensoy E, Balat O, Pençe S, Balat A, Cekmen M, Yurekli M.Malondialdehyde, nitric oxide and adrenomedullin levels in patients with primary dysmenorrhea.J Obstet Gynaecol Res. 2008 Dec;34(6):1049-53.

127-Unur M, Demirez E, Ağaçhan B, Görmüş U, Ergen A, Dalan B, Isbir T. The relationship of oral disturbances of diabetes mellitus patients with paraoxonase  gene polymorphisms. Cell Biochem Funct. 2008 Dec;26(8):870-3. PMID:19003935

128-Dalan AB, Ergen A, Yilmaz H, Karateke A, Isbir T. Manganese superoxide dismutase gene polymorphism, MnSOD plasma levels and risk of epithelial ovarian cancer. J Obstet Gynaecol Res. 2008 Oct;34(5):878-84. PMID:18834346

129-Tekeli A, Isbir S, Ergen A, Gormuş U, Bozkurt N, Timirci O, Arsan S, Isbir T. APE1 and XRCC3 polymorphisms and myocardial infarction. In Vivo. 2008 Jul-Aug;22(4):477-9.  PMID:18712175 impact factor:1,159

130-Gozu A, Ergen A, Dayicioglu D, Yaylim I, Ozsoy Z, Isbir T. L-myc polymorphism in head and neck nonmelanoma skin and lower lip cancers. Arch Otolaryngol Head Neck Surg. 2008 Jul;134(7):725-8. PMID:18645122

131-Yaylim-Eraltan I, Bozkurt N, Ergen A, Zeybek U, Ozturk O, Arikan S, Erbil Y,  Uslu I, Camlica H, Isbir T. L-myc gene polymorphism and risk of thyroid cancer. Exp Oncol. 2008 Jun;30(2):117-20. PMID:18566574

132-Kuran  Sibel Bulgurcuoglu,  Ergen  Arzu, Gormus  Uzay, Agachan  Bedia, Zeybek  Umit, Isbir Turgay. Serum Myeloperoxıdase Level And Gene Polymorphısm In Endometrıum Cancer . Antıcancer Res. 2008;28(5C);3298-3298.

133-Narter  Kamil Fehmi,  Ergen Arzu, Agachan  Bedia, Zeybek  Umit, Gormus  Uzay, Isbir  Turgay. Gene Polymorphısm In Bladder Cancer. Antıcancer Res. 2008;28(5C);3298-3298.

134-Ergen A, Isbir S, Tekeli A, Isbir T.. Investigation of ABCA1 C69T and G-191C polymorphisms in coronary artery disease. In Vıvo . 2008;22(2);187-190 PMID: 18468402

135-Isbir CS, Ergen A, Tekeli A, Zeybek U, Gormus U, Arsan S. The effect of NQO1 polymorphism on the inflammatory response in cardiopulmonary bypass. Cell Biochem Funct. 2008 Jun;26(4):534-8. PubMed PMID: 18098117. PMID:18098117

136-Ozger H, Kilicoglu O, Yilmaz H, Ergen HA, Yaylim I, Zeybek U, Isbir T. Methylenetetrahydrofolate reductase C677T gene polymorphism in osteosarcoma and chondrosarcoma patients. Folia Biol (Praha). 2008;54(2):53-7. PMID:18498722

2007 Publications

 137-Pence S, Erkutlu I, Kurtul N, Bosnak M, Tan U.Total brain tissue sialic acid levels due to glutathione effect in experimental epilepsy.Int J Neurosci. 2007 Nov;117(11):1523-35.

138-Isbir, SC, A Tekeli, A Ergen, H Yilmaz, K Ak, A Civelek, U Zeybek, S Arsan. Genetic polymorphisms contribute to acute kidney injury after coronary artery bypass grafting. Heart Surg Forum. 2007;10(6):E439-44.

139-Ergen HA, Gormus U, Narter F, Zeybek U, Bulgurcuoglu S, Isbir T. Investigation of NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism in prostate cancer. Anticancer Res. 2007 Nov-Dec;27(6B):4107-10.

140-Gormus U, Ergen A, Yaylim-Eraltan I, Yilmaz H, Turna A, Bozkurt N, Isbir T. Fas-1377 A/G polymorphism in lung cancer. In Vivo. 2007 Jul-Aug;21(4):663-6. impact factor:1,159

141-Ergen HA, Narter F, Timirci O, Isbir T. Effects of manganase superoxide dismutase Ala-9Val polymorphism on prostate cancer: a case-control study. Anticancer Res. 2007 Mar-Apr;27(2):1227-30. PubMed PMID: 17465268. impact factor:1,656

142-Gormus U, Ergen A, Yilmaz H, Dalan B, Berkman S, Isbir T. Fas-1377A/G and FasL-844 T/C gene polymorphisms and epithelial ovarian cancer. Anticancer Res. 2007 Mar-Apr;27(2):991-4.

143-Yigit B, Bozkurt N, Narter F, Yilmaz H, Yucebas E, Isbir T. Effects of ACE I/D polymorphism on prostate cancer risk, tumor grade and metastatis. Anticancer  Res. 2007 Mar-Apr;27(2):933-6.

144-Ozturk  Tulin,  Durak Haydar,  Ozturk  Oguz,  Isbir Turgay, Cakalir Canser. Investigation of CYP 1A1 and GST M1 gene polymorphisms and p53 immunhistochemical staining with clinical and pathologic features in patient with transitional cell bladder carcinoma. Vırchows Archıv. 2007;451(2);413-413.

145-Emre S, Sirin A, Ergen A, Bilge I, Sucu  A, Yilmaz A, Isbir  T. Methylenetetrahydrofolate reductase C677T polymorphism in patients with Henoch-Schonlein purpura. Pedıatrıc Nephrology. 2007;22(9);1539-1539.

146-Yaylim-Eraltan I, Arzu Ergen H, Arikan S, Okay E, Oztürk O, Bayrak S, Isbir T. Investigation of the VDR gene polymorphisms association with susceptibility to colorectal cancer. Cell Biochem Funct. 2007 Nov-Dec;25(6):731-7.

147-Zeybek U, Yaylim I, Yilmaz H, Ağaçhan B, Ergen A, Arikan S, Bayrak S, Isbir T. Methylenetetrahydrofolate reductase C677T polymorphism in patients with gastric and colorectal cancer. Cell Biochem Funct. 2007 Jul-Aug;25(4):419-22.

148-Yigit B, Bozkurt N, Berber I, Titiz I, Isbir T. Analysis of CC chemokine receptor 5 and 2 polymorphisms and renal transplant survival. Cell Biochem Funct. 2007 Jul-Aug;25(4):423-6.

149-Bilge I, Sirin A, Agachan B, Emre S, Sadikoglu B, Yilmaz H, Sucu A, Isbir T. Is paraoxonase 192 gene polymorphism a risk factor for membranoproliferative glomerulonephritis in children? Cell Biochem Funct. 2007 Mar-Apr;25(2):159-65.

150-Hekim N, Ergen A, Yaylim I, Yilmaz H, Zeybek U, Oztürk O, Isbir T. No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer. Cell Biochem Funct. 2007 Jan-Feb;25(1):115-7.

151-Aydin M, Ozkok E, Ozturk O, Agachan B, Yilmaz H, Yaylim I, Kebabcioglu S, Ispir T. Relationship between interleukin-8 and the oxidant-antioxidant system in end-stage renal failure patients. Exp Clin Transplant. 2007 Jun;5(1):610-3.

152-Ak, K., S. Isbir, A. Tekeli, A. Ergen, N. Atalan, S. Dogan, A.Civelek, S. Arsan. Presence of lipoprotein lipase S447X stop codon affects the magnitude of interleukin 8 release after cardiac surgery with cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2007; 134(2):477-83.

2006 Publications

 153-Kafadar AM,  Ergen A,  Zeybek U, Agachan  B, Kuday C , Isbir T. Paraoxonase 192 gene polymorphism and serum paraoxonase activity in high grade gliomas and meningiomas.Cell Biochem Funct. Sep-Oct 2006; 24(5):455-460

154-Biyikli NK,  Alpay H, Yildiz N,  Agachan B, Ergen A, Zeybek U, Bozkurt N,  Ispir T. Paraoxonase 1 192 and 55 polymorphisms in nephrotic children Pediatric Nephrology May 2006 2(5):649-654.

155-Kafadar AM,  Yilmaz H,  Kafadar D, Ergen A, Zeybek U, Bozkurt N, Kuday C, Isbir T. C677T Gene Polymorphism of Methylenetetrahydrofolate Reductase (MTHFR) In Meningiomas And High Grade Gliomas. Anticancer Res. 2006; 26:2445-2450

156-Guzel O., Inal Gultekin G., Cıraklı  Z.T., Eraslan  E., Aktaş M. Effects of propofol and sevoflurane anesthesia on some physiological and biochemical parameters in rabbits. Medycyna Weterynaryjina, 2006;62(12):1383-1386.

157-Yigit B, Bozkurt N, Yaylim I, Titiz I, Isbir T. Analysis of L-myc gene polymorphism in patients with renal failure outcome to renal transplant. Transplant Proc. 2006 Jun;38(5):1267-9. PubMed PMID: 16797278.

158-Zeybek U, Isbir T, Ergen HA, Yılmaz H, Hekim N, Akoglu E, The Effects Of Cholesteryl Ester Transfer Protein Taq1b Polymorphism In Renal Transplant Patients. Transplantation Proceedings 2006 38(5): 1382-1384

159-Yilmaz H, Isbir S, Agachan B, Ergen A, Farsak B, Isbir T. C677T mutation of methylenetetrahydrofolate reductase gene and serum homocysteine levels in Turkish patients with coronary artery disease. Cell Biochem Funct. 2006 Jan-Feb;24(1):87-90.

2005 Publications

 160-Cagli K, Bagci C, Gulec M, Cengiz B, Akyol O, Sari I, Cavdar S, Pence S, Dinckan H.In Vivo Effects of Caffeic Acid Phenethyl Ester on Myocardial Ischemia-Reperfusion Injury and Apoptotic Changes in Rats.Ann Clin Lab Sci. 2005 Autumn;35(4):440-8. impact factor:1,159

161-Agachan B, Yilmaz H, Ergen HA, Karaali ZE, Isbir T. Paraoxonase (PON1) 55 and 192 polymorphism and its effects to oxidant-antioxidant system in turkish patients with type 2 diabetes mellitus. Physiol Res. 2005;54(3):287-93. PubMed PMID: 15974833.

162-Okay E,  Karadenizli A, Muezzinoğlu B, Zeybek U, Ergen HA, Isbir T, N-Acetylcysteine attenuates bacterial translocation after partial hepatoctemy in rats. Journal of Surgical Research. 2005, 127(2):164-70

163-Yilmaz H, Isbir T, Agachan B, Karaali ZE. Effects of cholesterol ester transfer protein Taq1B gene polymorphism on serum lipoprotein levels in Turkish coronary artery disease patients Cell Bıochemıstry And Functıon Jan-Feb 2005 23(1): 23-28.

164-Karaali ZE, Agachan B, Yilmaz H ,Isbir T ,Angiotensin-converting enzyme I/D gene polymorphisms and effects of left ventricular hypertrophy in Turkish myocardial infarction patients. Acta Cardıologıca 2005 21 Oct 2004  59(5): 493-497.

2004 Publications

 165-Ergen HA, Hatemi H,  Agachan B, Camlica H, Isbir T. Angiotensin-I converting enzyme gene polymorphism in Turkish type 2 diabetic patients. Experımental And Molecular Medıcıne. Aug 31 2004 36(4): 345-350.

166-Ciftçi M, Ozmen I, Büyükokuroğlu ME, Pençe S, Küfrevioğlu OI. Effects of metamizol and magnesium sulfate on enzyme activity of glucose 6-phosphate dehydrogenase from human erythrocyte in vitro and rat erythrocyte in vivo. Clin Biochem. 2001 Jun;34(4):297-302.

167-Kurtul N, Pence S, Akarsu E, Kocoglu H, Aksoy Y, Aksoy H. Adenosine deaminase activity in the serum of type 2 diabetic patients. Acta Medica (Hradec Kralove). 2004;47(1):33-5.

168-Agachan B, Yilmaz H, Isbir T, Akoglu E, Paraoxonase 192 polymorphism and its relationship to serum lipids in Turkish renal transplant recipients. Transplantatıon Proceedıngs. Jun 2004  36(5): 1385-1386.

169-Isbir Turgay. Analysıs Of L-Myc Gene Polymorphısm In Breast, Gastrıc, Lung And Thyroıd Cancer. Antıcancer Res. 2004;24(5D);3523-3524.

170-Yilmaz H, Agachan B, Karaali ZE, Isbir T. Taq1B polymorphism of CETP gene on lipid abnormalities in patients with type II diabetes mellitus. Int J Mol Med. 2004 Jun;13(6):889-93.

171-Agachan B, Yilmaz H , Karaali Z , Isbir T,  Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non-insulin dependent diabetes mellitus. Cell Bıochemıstry And Functıon. May-Jun 2004 22( 3): 163-168.

172-Gurdol F, Işbilen E, Yilmaz H, Isbir T, Dirican A. The association between preeclampsia and angiotensin-converting enzyme insertion/deletion polymorphism.Clin Chim Acta. 2004 Mar;341(1-2):127-31. PubMed PMID: 14967168.

173-Oktem F, Sirin A , Bilge I, Emre S, Agachan B, Ispir T. ACE I/D gene polymorphism in primary FSGS and steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 2004 Apr;19(4):384-9. Epub 2004 Feb 21.

174-Yilmaz H, Unluçerçi Y, Gurdol F, Isbilen E, Isbir T. Association of pre-eclampsia with hyperhomocysteinaemia and methylenetetrahydrofolate reductase gene C677T polymorphism in a Turkish population. Aust N Z J Obstet Gynaecol. 2004 Oct;44(5):423-7. PubMed PMID: 15387863.

175-Yilmaz H, Agachan B, Ergen A, Karaalib ZE,  Isbir T ,  Methylene tetrahydrofolate reductase C677T mutation and left ventricular hypertrophy in Turkish patients with type II diabetes mellitus. Journal Of Bıochemıstry And Molecular Bıology.  Mar 31 2004 37(2): 234-238

2003 Publications

 176-Akgun S, Tekeli A, Isbir SC, Civelek A, Ak K, Sirvanci S, Arbak S, Yaylim I, Arsan S. FK506 to prevent lung injury after hindlimb ischemia and reperfusion in a rat model: an electronmicroscopic study. Surg Today. 2004;34(8):678-84.

177-“İsbir, C.S., K. Ak, Ö. Kurtkaya, Ü. Zeybek, S. Akgün, B.W. Scheitauer, A.Sav , A. Çobanoğlu.Ischemic Preconditioning and Nicotinamide in Spinal Cord Protection in an Experimental Model of Transient Aortic Occlusion. Eur J Cardiothorac Surg. 2003 Jun;23(6):1028-33.

178-Yaylim I, Bozkurt N, Yilmaz H, Isbir T, Isik N, Arikan S. The apolipoprotein  E epsilon 4 allele is not a risk factor for Turkish breast cancer patients.Cancer Genet Cytogenet. 2003 Oct 1;146(1):86-7. PubMed PMID: 14499704.

179-Yilmaz H, Agachan B, Ergen  HA, Karaali ZE, Isbir  T. Methylenetetrahydrofolate reductase C677T mutation has an important effect on hyperhomocysteinemia and left ventricul hypertrophy in patients with type II diabetes mellitus. Journal Of Hypertensıon.  2003;21(4);100-100.

180-Agachan B, Isbir T, Yilmaz H,  Akoglu E. Angiotensin converting enzyme I/D, angiotensinogen T174M-M235T and angiotensin II type 1 receptor A1166C gene polymorphisms in Turkish hypertensive patients. Exp Mol Med. 2003 Dec 31;35(6):545-9.

181-Ozturk O, Isbir T, Yaylim I, Kocaturk CI, Gurses A. GST M1 and CYP1A1 gene polymorphism and daily fruit consumption in Turkish patients with non-small cell  lung carcinomas. In Vivo. 2003 Nov-Dec;17(6):625-32. PubMed PMID: 14758730. impact factor:1,159

182-Isbir T,  Yilmaz H, Agachan B, Karaali ZE. Cholesterol ester transfer protein, apolipoprotein E and lipoprotein lipase genotypes in patients with coronary artery disease in the Turkish population. Clınıcal Genetıcs. Sep 2003 64(3): 228-234

183-Isbir T, Yaman A, Yaylim I, Yilmaz H, Oztürk O. Association between Apo B signal peptide gene polymorphism and NIDDM. Cell Biochem Funct. 2003 Jun;21(2):189-90. PubMed PMID: 12736910.

184-Agachan B, Yilmaz H, Karaali Z, Isbir T. Serum paraoxonase activity, and genotype distribution in diabetes mellitus and its relationship to serum lipids. Journal Of Hypertensıon . 2003;21(4);309-309.

185-Yilmaz H, Agachan B, Isbir T , Akoglu E. Is there additional effect of Mthfr C677t mutation on lipid abnormalities in renal allograft recipients? Transplantatıon Proceedıngs Jun 2003 35(4):1390-1392

2002 Publications

 186-Kurtul N, Pençe S, Kocoglu H, Aksoy H, Capan Y.Serum lipid and lipoproteins in gallstone patients.Acta Medica (Hradec Kralove). 2002;45(2):79-81.

187-Eren E, Yilmaz N, Pence S, Kocoglu H, Göksu S, Kocabaş R, Kadayifci S. Diagnostic value of C-reactive protein in patients with angiographically documented coronary heart disease. Acta Medica (Hradec Kralove). 2002;45(4):155-60.

188-Pençe S.Paw preference in rats.J Basic Clin Physiol Pharmacol. 2002;13(1):41-9.

189-Yaylim I, Isbir T. Enhanced casein kinase II (CK II) activity in human lung tumours. Anticancer Res. 2002 Jan-Feb;22(1A):215-8. PubMed PMID: 12017291.

190-Isbir T, Yaylim I, Arikan  S, Kaytan E, Karsidag T, Bayrak  S, Camlica H. Close Correlation Between Restriction Fragment Length Polymorphism Of L-Myc Gene And Susceptibility To Gastric Cancer. Cancer Detectıon And Preventıon.  2002;26(6);454-457

191-Yaylim I, Isbir T, Oztürk O, Turna A, Işitmangil T, Zonuzi F, Camlica H. Is there any correlation between restriction fragment length polymorphism of the L-MYC gene and metastasis of human nonsmall cell lung cancer? Cancer Genet Cytogenet. 2002 Apr 15;134(2):118-22. PubMed PMID: 12034523.

192-Isbir T, Yaylim I, Arıkan S, Kuçucuk S, Camlica H. Increased frequency of the S-allele of the L-myc oncogene in breast cancer. Mol Med. 2002 Sep;8(9):521-4. PubMed PMID: 12456990; PubMed Central PMCID: PMC2040019.

193-Isbir T, Yaylim I, Arikan S, Kaytan E, Karşidag T, Bayrak S, Camlica H. Close correlation between restriction fragment length polymorphism of L-myc gene and susceptibility to gastric cancer. Cancer Detect Prev. 2002;26(6):454-7. PubMed PMID: 12507230.

194-Satman I, Yilmaz T, Sengül A, Salman S, Salman F, Uygur S, Bastar I, Tütüncü Y, Sargin M, Dinççag N, Karsidag K, Kalaça S, Ozcan C, King H. Population-based study of diabetes and risk characteristics in Turkey: results of the turkishdiabetes epidemiology study (TURDEP). Diabetes Care. 2002 Sep;25(9):1551-6.

2001 Publications

 195-Yilmaz M, Bayazit YA, Erbagci I, Pençe S. Visual evoked potential changes in migraine.influence of migraine attack and aura. J Neurol Sci. 2001 Mar 1;184(2):139-41.

196-Isbir CS, Doğan R, Demircin M, Yaylim I, Paşaoğlu I.Aprotinin reduces the IL-8 after coronary artery bypass grafting. Cardiovasc Surg. 2001 Aug;9(4):403-6.

197-Yilmaz F, Isbir T,  Agachan B, Aydin M. Is epsilon 4 allele of apolipoprotein E associated with more severe end-organ damage in essential hypertension? Cell Bıochemıstry And Functıon. Sep 2001 19(3): 191-195

198-Isbir T, Agaçhan B, Yilmaz H, Aydin M, Kara I, Eker D, Eker E. Interaction between apolipoprotein-E and angiotensin-converting enzyme genotype in Alzheimer’s disease. Am J Alzheimers Dis Other Demen. 2001 Jul-Aug;16(4):205-10. PubMed PMID: 11501342.

199-Bozkurt N, Ozturk O, Isbir T. New MCAD gene mutation, not previously reported in other nations, found at A1161G in Turkish population. Am J Med Genet. 2001 Oct 15;103(3):255-6. PubMed PMID: 11746002.

200-Ildan F, Goçer AI, Tuna M, Polat S, Kaya M, Isbir T, Cetinalp E. The effects of the pre-treatment of intravenous nimodipine on Na(+)-K+/Mg+2 ATPase, Ca+2/Mg+2 ATPase, lipid peroxidation and early ultrastructural findings following middle cerebral artery occlusion in the rat. Neurol Res. 2001 Jan;23(1):96-104. PubMed PMID: 11210440.

201-Isbir T, Agaçhan B, Yilmaz H, Aydin M, Kara I, Eker E, Eker D. Apolipoprotein-E gene polymorphism and lipid profiles in Alzheimer’s disease. Am J Alzheimers Dis Other Demen. 2001 Mar-Apr;16(2):77-81. PubMed PMID: 11302074.

202-Isbir CS, Akgun S,  Yilmaz H, Civelek A , Ak K ,Tekeli A , Agachan B,  Cobanoglu A. Is there a role of angiotensin-converting enzyme gene polymorphism in the failure of arteriovenous femoral shunts for hemodialysis? Annals Of Vascular Surgery  Jul 2001; 15(4): 443-446

203-Oztaş B, Kiliç S, Dural E, Ispir T. Influence of antioxidants on the blood-brain barrier permeability during epileptic seizures. J Neurosci Res. 2001 Nov 15;66(4):674-8. PubMed PMID: 11746387.

204-Ozturk O ,Yaylim I, Aydin M, Yilmaz H , Agachan B, Demiralp E,  Isbir T. Increased plasma levels of interleukin-6 and interleukin-8 in beta-thalassaemia major. Haematologıa. 2001 31(3): 237-244

2000 Publications

 205-Agachan B, Yilmaz H, Aydin M, Isbir T. Is there any association between apolipoprotein E and angiotensin converting enzyme gene polymorphism in patients with Parkinson’s disease and dementia in Turkish Population? Neuroscıence Research Communıcatıons. Nov-Dec 2000; 27(3): 165-173

206-Oztaş B, Erkin E, Dural E, Isbir T. Influence of antioxidants on blood-brain barrier permeability during adrenaline-induced hypertension. Int J Neurosci. 2000 Nov;105(1-4):27-35. PubMed PMID: 11069044.

207-Koç M, Ozener IC, Tezcan H, Bihorac A, Isbir T, Akoğlu E. Left ventricular hypertrophy and angiotensin-converting enzyme gene polymorphism in renal allograft recipients. Transplant Proc. 2000 May;32(3):542-4. PubMed PMID:10812105.

208-Isbir T,  Agachan B, Yilmaz H, Aydin M. Angiotensin converting enzyme gene polymorphism in Alzheimer’s disease. Cell Biochem Funct. Jun 2000; 18(2): 141-142

209-Aydin M, Cengiz S,  Agachan B, Yilmaz H,  Isbir T. Age-related changes in GM1, GD1a, GT1b components of gangliosides in Wistar albino rats. Cell Biochem Funct. 2000 Mar;18(1):41-5.

210-Isbir T , Yaylim I , Aydin M , Ozturk O, Koyuncu H, Zeybek U, Agachan B, Yilmaz H. The effects of Brassica oleraceae var capitata on epidermal glutathione and lipid peroxides in DMBA-initiated-TPA-promoted mice. Anticancer Res. 2000 Jan-Feb;20(1A):219-24.
1999 Publications

 211-Yilmaz H, Agachan B, Aydin M, Isbir T. Association between apolipoprotein E and angiotensin converting enzyme genotype in essential hypertension. IUBMB Life. 1999 Aug;48(2):205-7.

212-Isbir  T. The Department of Molecular Medicine at the University of Istanbul, Institute of Experimental Medical Research. Molecular Medıcıne. 1999;5(2);69-70

1998 Publications

 213-Tan U, Pençe S, Tan M.The Prenatal Attenuation of Brain/Body Development Through Interactions Between Growth Hormone, Triiodothyronine and Testosterone During Prenatal Development of Female Neonates.Int J Neurosci. 1998 Sep;95(3-4):237-45.

 1997 Publications

 214-Isbir  T, Taylor A, Tamer L, Yucebilgic G,Oner  A. Zinc and selenium status of healthy children from the Central Anatolian region of Turkey. Trace Elements And Electrolytes . 1997;14(2);87-90

215-Isbir T, Yilmaz H, Bihorac A, Akoglu E. Mild-to-moderate hypertension and apolipoprotein E gene polymorphism. Am J Hypertens. 1997 Jul;10(7 Pt 1):827-8.PubMed PMID: 9234841.

1996 Publications

 216-Koçak R, Başlamişli F, Güvenç B, Tamer L, Aikimbaev KS, Isbir T. Bencyclane as an anti-sickling agent. Br J Haematol. 1996 Feb;92(2):329-31. PubMed PMID:8602994.

217-Ildan  F, Polat  S, Gocer AI, Oner  A, Isbir, T, Mete UO,  Kaya  M, Karadayi  A. The Effects Of The Pretreatment Of Intravenous High Dose Methylprednisolone On Na+-K+/Mg+2 Atpase And Lipid Peroxidation And Early Ultrastructural Findings Following Middle Cerebral Artery Occlusion İn The Rat. Acta Neurochırurgıca. 1996;138(3);338-345

218-Isbir T, Taylor A, Taner L, Kaleagasioglu F. Serum selenium levels of children living in Adana, Turkey.  Trace Elements And Electrolytes. 1996;13(3);136-137.

219-Ildan F, Polat S, Göcer AI, Oner A, Isbir T, Mete UO, Kaya M, Karadayi A.The effects of the pretreatment of intravenous high dose methylprednisolone on Na(+)-K(+)/Mg(+2) ATPase and lipid peroxidation and early ultrastructural findings following middle cerebral artery occlusion in the rat. Acta Neurochir (Wien). 1996;138(3):338-45. PubMed PMID: 8861704.

1995 Publications

 220-Ildan F, Polat S, Oner A, Isbır T, Gocer  AI, Tap O, Kaya M, Karadayi A. Effects Of Naloxone On Sodium-Activated And Potassium-Activated And Magnesium-Dependent Adenosine-5′-Triphosphatase Activity And Lipid-Peroxidation And Early Ultrastructural Findings After Experimental Spinal-Cord Injury. Neurosurgery. 1995;36(4): 797-80.

221-Itegın M, Gunay  I, Logoglu  G,  Isbır, T. Effects Of Static Magnetic-Field On Specific Adenosine-5′-Triphosphatase Activities And Bioelectrical And Biomechanical Properties In The Rat Diaphragm Muscle. Bioelectromagnetics. 1995;16(3);147-151

222-Ildan F, Oner A, Polat S, Isbir T, Göcer AI, Kaya M, Karadayi A. Correlation of alterations on Na(+)-K+/Mg+2 ATPase activity, lipid peroxidation and ultrastructural findings following experimental spinal cord injury with and without intravenous methylprednisolone treatment. Neurosurg Rev.1995;18(1):35-44. PubMed PMID: 7566528.

223-Isbir T, Tamer L, Erkisi  Kekec Y, Doran  F, Varinli S, Taylor A. Copper, Zinc And Magnesium In Serum And Tissues From Patients With Carcinoma Of Breast, Stomach And Colon. Trace Elements And Electrolytes. 1995;12(3);113-115

224-Isbir T, Kepekci  Y, Tamer L, Yucebilgic  G, Demirtas  M, Tukel S, Taylor A, Isbir M. Plasma Copper Levels In Ankylosing Spondilitis Patients With Cardiovascular Complications. Trace Elements And Electrolytes. 1995;12(3);119-121

225-Isbir T, Yucebilgic  G, Tamer  L, Baslamili F, Kocak  R,Taylor  A. Zinc, Copper, Magnesium And Sickle-Cell-Anemia. Trace Elements And Electrolytes. 1995;12(3);161-161

226-Itegin M, Gunay I, Logoglu G, Isbir T. Effects of static magnetic field on specific adenosine-5′- triphosphatase activities and bioelectrical and biomechanical properties in the rat diaphragm muscle. Bioelectromagnetics.1995;16(3):147-51. PubMed PMID: 7677790.

227-Ildan F, Polat S, Oner A, Isbir T, Cetinalp E, Kaya M, Karadayi A. The effect of the treatment of high-dose methylprednisolone on Na(+)-K(+)/Mg(+2) ATPase activity and lipid peroxidation and ultrastructural findings following cerebral contusion in rat. Surg Neurol. 1995 Dec;44(6):573-80. PubMed PMID:8669035.

İstanbul University © 2017 All Rights Reserved